(2) Divestitures

Electrical: On September 2, 2010, we completed the divestiture of our former Electrical business in Europe and Asia to Tinicum Capital Partners II, L.P., (“Tinicum”). Our net cash proceeds were approximately $53.3 million in cash, including normal working capital adjustments and other financial adjustments. On January 4, 2010, we divested Electrical's North American operations for an amount immaterial to our Consolidated Financial Statements. Electrical produced a full array of precious metal electrical contact products that range from materials used in the fabrication of electrical contacts to completed contact subassemblies. Net proceeds from each transaction, after funding related retirement plan obligations and transaction costs, were used to repay outstanding debt. During the year ended December 30, 2011, we recorded $0.6 million of other income to reflect updated estimates of the net proceeds we expect to receive upon the disposition of the remaining operations of Electrical, offset by $0.6 million of costs incurred in connection with the Electrical sale to reimburse the buyer for certain contingent costs that we were obligated to pay under the sale agreement. We have reflected the results of Electrical as discontinued operations on the Consolidated Statements of Operations for all periods presented. We have no material continuing involvement with our former Electrical business in Europe and Asia.

Electrical's net sales and earnings (loss) before income taxes included in discontinued operations for the years ended December 30, 2011, December 31, 2010, and December 25, 2009, respectively, were as follows (in thousands):

	Years Ended
	2011			2010			2009
Net sales	$	--		$	203,014		$	261,101
Loss before income taxes		(28	)		(9,491	)		(67,854	)

Medtech: On June 25, 2009, we completed the disposition of our Medtech components business to Altor Fund III (“Altor”). Medtech was headquartered in Roskilde, Denmark with manufacturing facilities in Denmark, Poland and Vietnam that produced components for the hearing aid and medical device markets. We had no activity related to Medtech during the year ended December 30, 2011. We reflected the results of Medtech as a discontinued operation on the Consolidated Statements of Operations for the year ended December 31, 2010. We have had no material continuing involvement with Medtech.

Medtech's net sales and earnings (loss) before income taxes included in discontinued operations for the years ended December 30, 2011, December 31, 2010, and December 25, 2009, respectively, were as follows (in thousands):

	Years Ended
		2011		2010		2009
Net sales	$	--	$	--	$	49,704
Earnings (loss) before income taxes		--		788		(44,025	)

MEMS: During 2009, we divested our microelectromechanical systems microphone business located in Denmark and Vietnam. We had no activity related to MEMS during the year ended December 30, 2011. We reflected the results of MEMs as a discontinued operation on the Consolidated Statements of Operations for the year ended December 31, 2010. We have had no material continuing involvement with MEMS.

MEMS net sales and loss before income taxes included in discontinued operations for the years ended December 30, 2011, December 31, 2010, and December 25, 2009, respectively, were as follows (in thousands):

	Years Ended
	2011		2010			2009
Net sales	$	--	$	188		$	1,532
Loss before income taxes		--		(142	)		(6,168	)